Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C

doi:10.3748/wjg.v16.i35.4394

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3773)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

341

HTML

2941

Figures (1-2)

248

Tables (1-2)

243

Sum=3773

Sep 21, 2010 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 21, 2010; 16(35): 4394-4399
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4394

Table 1 Case reports of interstitial pneumonitis associated with interferon therapy for hepatitis C virus

Ref.	Yr	Age (yr)/sex	Administered	Duration of IFN therapy (wk)	Diagnostic method	Treatment	Outcome
[1]	1993	60/F	IFNα-2b	8	C, R, B	D	Resolved
[2]	1994	58/F	IFN-α	12	C, R, B	D	Resolved
		56/M	IFN-α	6	C, R, B	D + S	Resolved
		72/F	IFN-α	3	C, R	D + S	Improvement
[3]	1994	48/F	IFN-α	9	C, R, B	D + S	Resolved
[4]	1994	62/F	IFN-α	3	C, R, B	D + S	Resolved
[5]	1996	49/F	IFNα-2b, Sho-saiko-to	6	C, R, B	D + S	Resolved
		59/M	IFNα-2b, Sho-saiko-to	4	C, R, B	D + S	Resolved
		42/M	IFNα-2b	16	C, R, B	D + S	Resolved
[6]	1996	46/M	IFN-α, Sho-saiko-to	4	C, R	D	Resolved
		57/M	IFN-α	5	C, R	D	Resolved
		59/M	IFN-α	23	C, R	D	Resolved
[7]	2001	57/M	IFN-α, ribavirin	12	C, R, B	D	Resolved
[8]	2002	48/F	IFNα-2b, ribavirin	24	C, R	D	Resolved
			PEGIFNα-2a, ribavirin	6	C, R, B	D + S	Improvement
		50/M	IFNα-2b, ribavirin	4	C, R, B	D + S	Resolved
[9]	2003	49/M	PEGIFNα-2b, ribavirin	2	C, R, B	D + S	Death
[10]	2004	71/F	PEGIFNα-2a, ribavirin	20	C, R, B	D	Resolved
[11]	2004	51/M	PEGIFNα-2b, ribavirin	5	C, R, B	D + S	Death
[12]	2005	58/F	PEGIFNα-2b, ribavirin	12	C, R, B	D + S	Resolved
			PEGIFNα-2a, ribavirin	12	C, R	D	Resolved
[13]	2006	68/F	IFNα-2b, ribavirin	14	C, R, B	D + S	Resolved
[14]	2007	47/F	PEGIFNα-2b, ribavirin	10	C, R, B	D + S	Resolved
[15]	2008	43/F	PEGIFNα-2b, ribavirin	48	C, R	D + S	Death
[16]	2009	39/F	PEGIFNα-2a, ribavirin	36	C, R, B	D + S	Resolved
[17]	2010	51/M	PEGIFNα-2b, ribavirin	4	C, R, B	D + S	Resolved

B: Biopsy proven diagnosis; C: Clinical diagnosis; R: Radiological diagnosis; PEGIFN-α: Pegylated interferon α; D: Discontinuation IFN-α; S: Corticosteroids therapy.

Table 2 Clinical data about patients in two subgroups

Severity of IP	Cases, n (%)	Sex (M/F)	Age (yr, mean)	Duration of IFN therapy (wk, mean)	Steroid therapy
Severe group	8 (36)	4/4	57.1	5.9	6/2
M and M group	14 (64)	7/7	52.1	14.4	9/7
P value	--	1.00	0.201¹	0.041²	0.43

¹U = 31.5, W = 109.5;

²U = 20.5, W = 53.5, P < 0.05 by Mann-Whitney test. M and M group: Mild or moderate pulmonary functional impairment group. IP: Interstitial pneumonitis; IFN: Interferon.

Citation: Ji FP, Li ZX, Deng H, Xue HA, Liu Y, Li M. Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C. World J Gastroenterol 2010; 16(35): 4394-4399
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4394.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4394